Ündar, L. Et Al. 2022. Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature. Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.9 , 702-707.

Ündar, L., Atas, U., Iltar, U., Salim, O., Yücel, O. K., & Alpsoy, E., (2022). Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature. Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.9, 702-707.

Ündar, LEVENT Et Al. "Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature," Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.9, 702-707, 2022

Ündar, LEVENT Et Al. "Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature." Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.9, pp.702-707, 2022

Ündar, L. Et Al. (2022) . "Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature." Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.9, pp.702-707.

@article{article, author={LEVENT ÜNDAR Et Al. }, title={Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature}, journal={Clinical Lymphoma, Myeloma and Leukemia}, year=2022, pages={702-707} }